Vertical transmission of HIV - Pregnancy and infant issues

HIV/AIDS in South Africa 25 Years On: Psychosocial Perspectives

Volumn , Issue , 2009, Pages 183-204

  Sherr, Lorraine ^a  

^a Portex Respiratory Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858773247     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0306-8_13     Document Type: Chapter

References (109)

1. Abdool Karim, Q.A., Abdool Karim, S.S., Coovadia, H.M., and Susser, M. (1998). Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary? American Journal of Public Health, 88, 637-640
2. Ahluwalia, I.B., DeVellis, R.F., and Thomas, J.C. (1998). Reproductive decisions of women at risk for acquiring HIV infection. AIDS Education and Prevention, 10(1), 90-97.
3. Antelman, G., Smith, F.M.C., Kaaya, S., et al. (2001). Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS, 15, 1865-1874.
4. Arrivé, E., Newell, M.L., Ekouevi, D.K., Chaix, M.L., Thiebaut, R., Masquelier, B., Leroy, V., Perre, P.V., Rouzioux, C., and Dabis, F. (2007). Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a metaanalysis. International Journal of Epidemiology, 36(5), 1009-1021.
5. Barbacci, M.B., Dalabetta, G., Repke, B., et al. (1990). Human Immunodeficiency Virus Infection in Women Attending an Inner-City Prenatal Clinic: Ineffectiveness of Targeted Screening. Sexually Transmitted Diseases, 17, 122-126.
6. Behrendt, C., Kendig, N., Dambita, C., Horman, J., Lawlor, J., and Vlahov, D. (1994). Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. American Journal of Epidemiology, 139, 918-926.
7. Bell, C., Richardson, D., Wall, M., and Goldmeier, D. (2006). HIV-associated female sexual dysfunction clinical experience and literature review. International Journal of STD and AIDS, 17(10), 706-709.
8. Bergenström, A., Sherr, L., Okolo, S., and Okolo, S. (1999). HIV testing and prevention: family planning clinic attenders in London. Sexually Transmitted Infections, 75(2), 130.
9. BHIVA (2007). Standards for HIV Clinical Care. Policy Document, March 2007
10. Brown, G.R., and Rundell, J.R. (1993). A prospective study of psychiatric aspects of early HIV disease in women. General Hospital Psychiatry, 15(3), 139-147.
11. Brunham, R.C., Garnett, G.P., Swinton, J., and Anderson, R.M. (1991). Gonococcal infection and human fertility in sub-Saharan Africa. Proceedings of the Royal Society of Biological Sciences, 246(1316), 173-177.
12. Brunham, R.C., Cheang, M., McMaster, J., Garnett, G., and Anderson, R. (1993). Chlamydia trachomatis, infertility, and population growth in sub-Saharan Africa. Sexually Transmitted Diseases, 20(3), 168-173.
13. Cartoux, M., Msellati, P., Meda, N., et al. (1998). Attitude of pregnant women towards HIV testing in Abidjan, Cote d'Ivoire and Bobo-Dioulasso, Burkina Faso. AIDS, 12, 2337-2344.
14. Ciccarone, D.H., Kanouse, D.E., Collins, R.L., Miu, A., Chen, J.L., Morton, S.C., Stall, R. (2003). Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American Journal of Public Health, 93, 949-954.
15. Coll, O., Fiore, S., Floridia, M., Giaquinto, C., Grosch-Worner, I., Guiliano, M., et al. (2002). Pregnancy and HIV infection: A european consensus on management. AIDS, 16, S1-S18.
16. Connor, E.M., Sperling, R.S., Gelber, R., et al. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. The New England Journal of Medicine, 331, 1173-1180.
17. Cooper, E.R., Charurat, M., Mofenson, L., et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndrome, 29, 484-494.
18. Coovadia, H., and Kindra, G. (2008). Breastfeeding to prevent HIV transmission in infants: balancing pros and cons. Current Opinion in Infectious Diseases, 21(1), 11-15.
19. Coovadia, H.M., and Schaller, J.G. (2008). HIV/AIDS in children: a disaster in the making. Lancet, 372 (9635), 271-273.
20. Coovadia, H.M., Coutsoudis, A., and Rollins, N.C. (2008). Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. The New England Journal of Medicine, 359(17), 1846.
21. Dabis, F., Msellati, P., Meda, N., et al. (1999). Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d Ivoire and Burkina Faso; a double-blind placebo-controlled multicentre trial. Lancet, 353, 786-792.
22. Dabis, F., Leroy, V., Castetbon, K., Spira, R., Newell, M., Salamon, R. (2000). Preventing motherto-child transmission of HIV-1 in Africa in the year 2000. AIDS, 14, 1017-1026
23. Dalzell, F., Farkas, A.G., Hawken, J. and Hudson, C.N. (1995). Antenatal testing for HIV antibody: problems of documentation and record. AIDS Care, 7, 129-33.
24. Dawson, J.M., Fitzpatrick, R.M., Reeves, G., et al. (1994). Awareness of sexual partners' HIV status as an influence upon high-risk sexual behavior among gay men. AIDS, 8, 837-841.
25. Denayer, M., Piot, P., Jonckheer, T., and Stroobant, A. (1990). HIV screening during pregnancy. Results of two attitude surveys on antenatal HIV screening in Belgium. Acta Clinica Belgica, 45, 299-305.
26. De Ruiter, A. et al., (2008). Guidelines Pregnancy and HIV. British HIV Association.
27. Dube, S., Boily, M., Mugurungi, O., Mahomva, A., Chikhata, F., and Gregson, S. (2008). Estimating vertically acquired HIV infections and the impact of the prevention ofmother-to-child transmission program in Zimbabwe: insights from decision analysis models. Journal of Acquired Immune Deficiency Syndromes, 48(1), 72-81.
28. Ergin, A., Magnus, M., and Ergin, N. (2002). He J Short course antiretroviral treatment in the prevention of perinatal HIV-1 transmission. A meta-analysis of randomized controlled trials. Annals of Epidemiology, 12(7), 521.
29. European Collaborative Study. (2005). Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 40, 458-465.
30. Fakoya, A., Lamba, H., Mackie, N., Nandwani, R., Brown, A., Bernard, E., Gilling-Smith, C., Lacey, C., Sherr, L., Claydon, P., Wallage, S., and Gazzard, B. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Medicine, 9(9), 681-720.
31. Fiore, S., Heard, I., Thorne, C., Savasi, V., Coll, O., Malyuta, R., Niemiec, T., Martinelli, P., and Tibaldi, C. (2008). Newell ML. Reproductive experience of HIV-infected women living in Europe. Human Reproduction, 23(9), 2140-2144.
32. Fitzgerald, D.W., Marotte, C., Verdier, R.I., Johnson,W.D., and Pape, J.W. (2002). Comprehension during informed consent in a less-developed country. Lancet, 360, 1301-1302.
33. Florence, E., Schrooten, W., Dreezen, C., Gordillo, V., Nilsson, Schonnesson, L., Asboe, D., et al. (2004). Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care, 16(5), 550-557.
34. Freeman, G., Glynn, J., Study Group on heterogeneity of HIV in African Cities. (2004). Factors affecting heterogeneity of HIV epidemics in African Cities. Factors affecting HIV concordancy in married couples in four African cities. AIDS, 18, 1715-1720.
35. Geary, M.K., King, G., Forsberg, A.D., Delaronde, S.R., Parsons, J. (1996). Issues of disclosure and condom use in adolescents with Hemophilia and HIV. Pediatric AIDS and HIV Infection, 7, 418-423
36. Geddes, R., Knight, S., Reid, S., Giddy, J., Esterhuizen, T., and Roberts, C. (2008). Prevention of mother-to-child transmission of HIV programme: low vertical transmission in KwaZulu-Natal, South Africa. The South African Medical Journal, 98(6), 458-462.
37. Gilling-Smith, C., Emiliani, S., Almeida, P., Liesnard, C., and Englert, Y. (2005). Laboratory safety during assisted reproduction in patients with blood-borne viruses. Human Reproduction, 20(6), 1433-1438.
38. Gray, G.E., and McIntyre, J.A. (2007). HIV and pregnancy. British Medical Journal, 334(7600), 950-953.
39. Gray, R.H., Wawer, M.J., Serwadda, D., Sewankambo, N., Li, C., Wabwire-Mangen, F., Paxton, L., Kiwanuka, N., Kigozi, G., Konde-Lule, J., Quinn, T.C., Gaydos, C.A., and McNairn, D. (1998). Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet, 351(9096), 98-103.
40. Guay, L.A., Musoke, P., Fleming, T., et al. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 354, 795-802.
41. Guthrie, B.L., de Bruyn, G., and Farquhar, C. (2007). HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy. Current HIV Research, 5(4), 416-429.
42. Hankins, C., Tran, T., and Lapointe, N. (1998). Sexual behavior and pregnancy outcome in HIVinfected women. Canadian Women's HIV Study Group. Journal of Acquired Immune Deficiency Syndromes, 18(5), 479-487.
43. Henry, K., Willenbring, K., and Crossley, K. (1988). Human Immunodeficiency Virus Antibody Testing: A Description of Practices and Policies at US Infectious Disease-Teaching Hospitals and Minnesota Hospitals. Journal of the American Medical Association, 259, 1819-1822
44. Hudson, C.N., Bergenström, A., Bell, E., McCann, E., and Sherr, L. (1999). The dilemma of antenatal HIV testing: what goes on in the European Community?. Journal of Royal Society Medicine, 92(6), 273-276.
45. Hull, H., Bettinger, C., and Gallaher, R. (1988). Comparison of HIV antibody prevalence in patients consenting to and declining HIV antibody testing in an STD clinic. The Journal of American Medical Association, 260, 935-8
46. Irwin, K.L., Valdiserri, R.O., and Holmberg, S.D. (1996). The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS, 10(14), 1707-1717.
47. Jackson, J.B., Musoke, P., Fleming, T., et al. (2003). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet, 362, 859-868.
48. Jenum P. (1988). Anti-HIV screening of pregnant women in south-eastern Norway. NIPH Ann.,11(2):53-58
49. JLICA-Joint Learning Initiative on Children and AIDS (2009). Available from http://www.jlica.org/resources/publications.php
50. Jones, J., Hutto, P., Meyer, P., Dowda, H., Gamble, W., and Gunn, R. (1993). HIV seroprevalence and reasons for refusing and accepting HIV testing. Sexually Transmited Diseases, 20, 334-337
51. Jones, T.B. (2008). Psychosocial dimensions of HIV infection in pregnancy. Clinical Obstetrics and Gynecology, 51(2), 456-466.
52. Kalichman, S.C., Nachimson, D. (1999). Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychology, 18, 281-287.
53. Keegan, A., Lambert, S., and Petrak, J. (2005). Sex and relationships for HIV-positive women since HAART: a qualitative study. AIDS Patient Care STDS, 19(10), 645-654.
54. Kurth, A. (1993). Reproduction issues pregnancy and childbearing in HIV infected women. In F.R. Cohen, and J.D. Durham (Eds.), Women children and HIV/AIDS (pp. 104-133). New York: Springer.
55. Kwalambota, M. (2002). The effect of pregnancy in HIV infected women. AIDS Care, 14(3), 431-433.
56. Lallemant, M. (2000). A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. The New England Journal of Medicine, 343, 982-991.
57. Lallemant, M., Jourdain, G., Le Coeur, S., et al. (2004). Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. The New England Journal of Medicine, 351, 217-228.
58. Lancet. (2008). A grave delay for South Africa's mothers and infants. The Lancet, 371(9610), 360.
59. Larsson, G., Spangberg, L., Lindgren, S., and Bohlin, A.B. (1990). Screening for HIV in pregnant women: a study of maternal opinion. AIDS Care, 2, 223-228.
60. Leroy, V. (2003). Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa: a pooled analysis of two randomised clinical trials. AIDS, 17, 1493-1501.
61. Leroy, V., Karon, J.M., Alioum, A., et al. (2002). Twenty-four month efficacy of a maternal shortcourse zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS, 16, 631-641.
62. Little, K.E., Bland, R.M., and Newell, M.L. (2008) Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings. Tropical Medicine &International Health, 13(9), 1098-1110
63. MacDonald S.E., Hartling L.A., Seguin R.M., OConnor K.S., Rekart M.L.,Mowat D.L., and Hoey J.R. (2001). Screening for HIV during pregnancy. Survey of physicians' practices. Canadian Family Physician, 47, 2250-2257.
64. Madge, S., Phillips, A.N., Griffioen, A., Olaitan, A., and Johnson, M.A. (1998). Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV. International Journal of Epidemiology, 27(6), 1068-1071.
65. Maman, S., Mbwambo, J.K., Hogan, N.M., Weiss, E., Kilonzo, G.P., and Sweat, M.D. (2003) High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS and Behavior, 7(4), 373-382
66. Maman, S., Moodley, D., Groves, A., and Smith, E. (2007). Integrating health, psychosocial and legal support for pregnant women in South Africa. HIV/AIDS Policy and Law Review, 12(2-3), 61-3.
67. Mandelbrot, L., Landreau-Mascaro, A., Rekacewicz, C., et al. (2001). Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. The Journal of American Medical Association, 285, 2083-2093.
68. Manzi, M., Zachariah, R., Teck, R., Buhendwa, L., Kazima, J., Bakali, E., Firmenich, P., and Humblet, P. (2005). High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Tropical Medicine and International Health, 10(12), 1242-1250.
69. Marks, G., and Crepaz, N. (2001). HIV-positive men-s sexual practices in the context of selfdisclosure of HIV status. Journal of Acquired Immune Deficiency Syndromes, 27, 79-85
70. Mayfield, A.E., Rice, E., Flannery, D., and Rotheram-Borus, M.J. (2008). HIV disclosure among adults living with HIV. AIDS Care, 20(1), 80-92.
71. Medley, A., Garcia-Moreno, C.,McGill, S., andMaman, S. (2004). Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bulletin of the World Health Organisation, 82(4), 299-307.
72. Mofenson, L.M. (2004). Successes and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 serosurvey of childbearing women. Archives of Pediatrics &Adolescent Medicine, 158, 422-425.
73. Niccolai, L.M., Dorst, D., Myers, L., and Kissinger, P.J. (1999) Disclosure of HIV status to sexual partners: predictors and temporal patterns. Sexually Transmitted Diseases, 26, 281-285.
74. Niccolai, L.M., King, E., D-entremont, D., and Pritchett, E.N. (2006). Disclosure of HIV serostatus to sex partners: A new approach to measurement. Sexually Transmited Diseases, 33, 102-105.
75. Nyamath, A., and Stein, J. (1997). Assessing the impact of HIV risk reduction counseling in impoverished African American women a structured equation approach. AIDS Education and Prevention, 9, 253-273.
76. Olley, B.O., Seedat, S., Stein, D.J. (2004). Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. African Journal of Reproductive Health, 8, 71-76.
77. Parsons, J., Missildine, W., Van Ora, J., et al. (2004). HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDs, 8, 457-468.
78. Pelton, J., Forehand, R., Morse, E., Morse, P.S., and Stock, M. (2001). Father-child contact in inner-city African American families with maternal HIV infection. AIDS Care, 13(4), 475-480.
79. Petra Study Group. (2002). Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet, 359, 1178-1186.
80. Petrak, J.A., Doyle, A.M., Smith, A., Skinner, C., and Hedge, B. (2001). Factors associated with self disclosure of HIV serostatus to significant others. British Journal of Health Psychology, 6, 69-79.
81. Postma, M.J., Beck, E.J., Hankins, C.A., Mandalia, S., Jager, J.C., de Jong-van den Berg, L.T., et al. (2000). Cost effectiveness of expanded antenatal HIV testing in London. AIDS, 14(15), 2383-2389.
82. Postma, M.J., Beck, E.J., Mandalia, S., Sherr, L., Walters, M.D., Houweling, H., et al. (1999). Universal HIV screening of pregnant women in England: cost effectiveness analysis. British Medical Journal, 318, 1656-1660.
83. Raj, A., Cheng, D.M., Levison, R., Meli, S., and Samet, J.H. (2006). Sex trade, sexual risk, and nondisclosure of HIV serostatus: Findings from HIV-infected persons with a history of alcohol problems. AIDS and Behavior, 10, 149-157.
84. Rey, D., Obadia, Y., Carrieri, M., and Moatti, J. (1998). HIV screening for pregnant women in south eastern France, evolution 1992-1994-1996. European Journal of Obstetrics, Gynecology and Reproductive Biology, 76(1), 5-9.
85. Rochat, T.J., Richter, L.M., Doll, H.A., Buthelezi, N.P., Tomkins, A., and Stein, A. (2006). Depression among pregnant rural South African women undergoing HIV testing. The Journal of American Medical Association, 295(12), 1376-1378.
86. Semple, S., Patterson, T., Temoshok, L.,McCutchan, J., Straits-Troster, K., Chandler, J., and Grant, I. (1993). Identification of psychobiological stressors among HIV positive women. Women Health, 20(4), 15-36.
87. Shaffer, N., Chuachoowong, R., Mock, P.A., et al. (1999) Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised, controlled trial. Lancet, 353, 773-780.
88. Shapiro, R.L., Thior, I., Gilbert, P., et al. (2006). Maternal single-dose nevirapine vs. placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS, 20(1), 281-1288.
89. Sherman, G.G., Stevens, G., Jones, S.A., Horsfield, P., and Stevens, W.S. (2005). Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. Journal of Acquired Immune Deficiency Syndromes, 38, 615-617.
90. Sherr, L. (1999). Counselling and HIV testing: ethical dilemmas. In R. Bennett, and C. Erin (Eds.), HIV and AIDS, testing screening and confidentiality. Oxford: University Press.
91. Sherr, L. (2005). Young children and HIV/AIDS: Mapping the field. The Hague: Bernard van Leer Publications.
92. Sherr, L., Mueller, J., and Varrall, R. (2008). Strengthening families through HIV/AIDS prevention, treatment, care and support: A review of the literature. Joint Learning Initiative on Children and AIDS. Available from: http://www.jlica.org/userfiles/file/Sherr%20JLICA%20LG1%20Paper%20Brief.pdf accessed 1/3/2009
93. Sherr, L., and Barry, N. (2004). Fatherhood and HIV-positive heterosexual men. HIV Medicine, 5(4), 258-263.
94. Sherr, L., Bergenstrom, A., and Hudson, C.N. (2000). Consent and antenatal HIV testing the limits of choice and issues of consent in HIV and AIDS. AIDS Care, 12(3), 307-312
95. Sherr, L., Bergenstrom, A., Bell, E., McCann, E., and Hudson, C.N. (2001) Ante-natal HIV testing: an observational study of HIV test discussion in maternity care. Counselling Psychology Quarterly, 14, 129-138.
96. Shetty, A.K., Marangwanda, C., Stranix-Chibanda, L., Chandisarewa, W., Chirapa, E., Mahomva, A., Miller, A., Simoyi, M., and Maldonado, Y. (2008). The feasibility of preventing mother-tochild transmission of HIV using peer counselors in Zimbabwe. AIDS Research and Therapy, 5, 7.
97. Simbayi, L.C., Kalichman, S.C., Strebel, A., Cloete, A., Henda, N., and Mqeketo, A., (2007). Disclosure of HIV status to sex partners and sexual risk behaviors among HIV positive men and women in Cape Town, South Africa. Sexually Transmitted Infections, 83(1), 29-34.
98. Simon, P.A., Weber, M., Ford, W.L., Cheng, F. and Kerndt (1996). Reasons for HIV antibody test refusal in a heterosexually transmitted disease clinic population. AIDS, 10(3), 1549-1553.
99. Sowell, R., Murdaugh, C., Addy, L., Moneyham, L., and Tavokoli. (2002). Factors influencing intent to get pregnant in HIV infected women living in the southern USA. AIDS Care, 14(2), 181-192.
100. Stein, M.D., Freedberg, K.A., Sullivan, L.M., et al. (1998). Sexual ethics. Disclosure of HIVpositive status to partners. Archives of Internal Medicine, 158, 253-257.
101. Suksomboon, N., Poolsup, N., and Ket-Aim, S. (2007). Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. Journal of Clinical Pharmacy and Therapeutics, 32(3), 293-311.
102. Sullivan, K.M. (2005). Male self-disclosure of HIV-positive serostatus to sex partners: a review of the literature. Journal of the Association of Nurses in AIDS Care, 16(6), 33-47.
103. UNAIDS (2008). Report on the Global HIV/AIDS Epidemic. UNAIDS: Geneva.
104. Varga, C., and Brookes, H. (2008). Factors influencing teen mothers enrollment and participation in prevention of mother-to-child HIV transmission services in Limpopo Province, South Africa. Qualitative Health Research, 18(6), 786-802.
105. Waters, L., Gilling-Smith, C., and Boag, F. (2007). HIV infection and subfertility. International Journal of STD and AIDS, 18(1), 1-6.
106. WHO. (2006). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Recommendations for a public health approach 2006.
107. Wiener, L.S., Vasquez, M.J., and Battles, H.B. (2001). Brief report: fathering a child living with HIV/AIDS: psychosocial adjustment and parenting stress. Journal of Pediatric Psychology, 26(6), 353-358.
108. Wiktor, S.Z., Ekpini, E., Karon, J.M., et al. (1999). Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d-Ivoire: a randomised trial. Lancet, 353, 781-785.
109. Wolitski, R.J., Rietmeijer, C.A.M., Goldbaum, G.M., Wilson, R.M. (1998). HIV serostatus disclosure among gay and bisexual men in four American cities: general patterns and relation to sexual practices. AIDS Care, 10, 599-610.